K Number
K141095
Device Name
STRYKER STERI-SHIELD FLYTE HYBRID TOGAS
Date Cleared
2014-08-26

(120 days)

Product Code
Regulation Number
878.4040
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Stryker Steri-Shield Flyte Hybrid Togas are components of a personal protection system and are intended to protect the patient, healthcare personnel, and operating room personnel against contamination, exposure of infectious bodily fluids, the transfer of microorganisms and particulate material. The togas are sterile and single use only.
Device Description
The Steri-Shield Flyte Hybrid Togas are single use, sterile, disposable devices that comprise part of the Steri-Shield Flyte Hybrid Personal Protection System. They are intended to be worn by healthcare personnel to protect the patient and healthcare personnel against contamination, exposure of infectious bodily fluids and the transfer of microorganisms and particulate material. The devices are prescription use.
More Information

Not Found

No
The device description and intended use clearly define the product as a disposable protective garment, with no mention of AI/ML capabilities or related data/performance metrics.

No
The device is described as a component of a personal protection system intended to protect against contamination and transfer of microorganisms, not to treat or cure a disease or condition.

No

Explanation: The device is described as personal protective equipment (togas) intended to protect against contamination and transfer of materials, not to diagnose medical conditions.

No

The device description clearly states the device is a physical, disposable garment ("togas") intended to be worn, indicating it is a hardware device, not software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the togas are for protecting patients and healthcare personnel from contamination, infectious bodily fluids, microorganisms, and particulate material. This is a barrier function for personal protection, not a diagnostic test performed in vitro (outside the body) on biological samples.
  • Device Description: The description reinforces the purpose as a protective garment worn by healthcare personnel.
  • Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Detecting or measuring specific substances (analytes)
    • Providing information for diagnosis, monitoring, or screening of diseases or conditions.

The device is a personal protective equipment (PPE) designed to prevent the spread of contamination, which falls under a different regulatory category than IVDs.

N/A

Intended Use / Indications for Use

The Stryker Steri-Shield Flyte Hybrid Togas are components of a personal protection system and are intended to protect the patient, healthcare personnel, and operating room personnel against contamination, exposure of infectious bodily fluids, the transfer of microorganisms and particulate material.

The togas are sterile and single use only.

Product codes (comma separated list FDA assigned to the subject device)

FYA

Device Description

The Steri-Shield Flyte Hybrid Togas are single use, sterile, disposable devices that comprise part of the Steri-Shield Flyte Hybrid Personal Protection System. They are intended to be worn by healthcare personnel to protect the patient and healthcare personnel against contamination, exposure of infectious bodily fluids and the transfer of microorganisms and particulate material. The devices are prescription use.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Operating room personnel

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Results of performance testing demonstrate that the functionality, integrity, and Performance Data (Non Clinical Tests): safety and effectiveness of the Steri-Shield Flyte Hybrid Togas are sufficient for their intended use and support a determination of substantial equivalence.

Biocompatibility testing was performed on the subject device in accordance with ANSI/AAMI/ISO 10993-1:2009: Biological Evaluation of Medical Devices-Part 1: Evaluation and AAMI Standards and Recommended Practices, Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices. Results of testing validate the subject device is non-cytotoxic, non-sensitizing, and a negligible irritant.

Stryker Steri-Shield Flyte Hybrid Togas will be available only in sterile packaged form. The sterile product will be terminally sterilized using ethylene oxide (EO). The sterilization method was validated and performed in accordance with ANSI/AAMI/ISO 11135-1:2007, Sterilization of health care products - Ethylene oxide. A sterility assurance level of 10 ° has been validated for this product.

Results from the following tests indicate specifications were met:
Lint Level (ISO 9073 part 10)
Tensile Strength (BS EN 29073-3)
Tear Resistance (Flyte Hybrid: ASTM D 5587-08; Flyte: ASTM D 5733)
Evaporative resistance (ASTM F 1868)
Bacterial Filtration Efficiency per ASTM F2101-07
Particulate Filtration Efficiency per ASTM F2299-03
Viral Penetration (per ASTM F1671) Level 4 Critical Zone as defined in AAMI/ANSI PB70 (for Front/Sleeve material and Sleeve Seam), but not for hood region material.
Water Resistance: Impact Penetration (per AATCC 42) Level 1 Critical Zone as defined in AAMI/ANSI PB70
Biocompatibility (in vitro cytotoxicity, primary skin irritation, skin sensitization)
Flammability (No Flame Spread per 16 CFR Part 1610)
Finished (Terminal) Product Sterilization Method (SAL 10-6, Ethylene Oxide in accordance with ISO 11135-1)

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Stryker Steri-Shield Flyte Togas (K073017)

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4040 Surgical apparel.

(a)
Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.(b)
Classification. (1) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption:(i) The user contacting components of the device must be demonstrated to be biocompatible.
(ii) Analysis and nonclinical testing must:
(A) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
(B) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
(iii) NIOSH approved under its regulation.
(2) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.

0

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-000

August 26, 2014

Stryker Instruments Ms. Julia L. Helgeson Senior Regulatory Representative 4100 E. Milham Ave Kalamazoo, MI 49001

Re: K141095

Trade/Device Name: Stryker Steri-Shield Flyte Hybrid Togas Regulation Number: 21 CFR 878.4040 Regulation Name: Surgical Apparel Regulatory Class: Class II Product Code: FYA Dated: July 30, 2014 Received: July 31, 2014

Dear Ms. Helgeson.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA mav publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

1

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Erin I. Keith -S

Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Section 4 Indications for Use Statement

3

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.

510(k) Number (if known) K141095

Device Name Styker Steri-Shield Flyte Hybrid Togas

Indications for Use (Describe)

The Stryker Steri-Shield Flyte Hybrid Togas are components of a personal protection system and are intended to protect the patient, healthcare personnel, and operating room personnel against contamination, exposure of infectious bodily fluids, the transfer of microorganisms and particulate material.

The togas are sterile and single use only.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

4

4100 E. Milham Ave.
Kalamazoo, MI 49001
t: 269 329 7000 f: 269 389 5412 www.stryker.com

510(k) Summary

| 510(k) Owner: | Stryker Instruments
4100 E. Milham Avenue
Kalamazoo, MI 49001
(p) 269-329-7000
(f) 269-389-5412 | | | | |
|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------|----------------------|-------|---------------------------------|
| Contact Person: | Julia L. Helgeson
Sr. Regulatory Affairs Representative | | | | |
| Registration Number: | 1811755 | | | | |
| Date Summary Prepared: | June 25, 2014 | | | | |
| Trade Name(s): | Stryker Steri-Shield Flyte Hybrid Togas | | | | |
| Common Name: | Surgical Apparel | | | | |
| Classification Data: | Product Code | Device | Regulation
Number | Class | Review
Panel |
| | FYA | Gown, Surgical | 21 CFR 878.4040 | ll | General &
Plastic
Surgery |
| Reason for 510(k)
Submission: | Special 510(k): Device Modifications with no change to fundamental scientific
technology or intended use. | | | | |
| Device Modification: | Stryker submits this Special 510(k): Device Modification for our Steri-Shield Flyte
Togas. The modifications are as follows: | | | | |
| | Change in material utilized in hood region of toga

Change in material formulation of barrier material

Dimensional changes for user fit

Minor design modifications to component attachment methods
● | | | | |
| | The modification changes neither the intended use, the indications for use, nor the
fundamental scientific technology. | | | | |
| Predicate SE Device(s): | Stryker Steri-Shield Flyte Togas (K073017) | | | | |
| Indications for Use: | The Stryker Steri-Shield Flyte Hybrid Togas are components of a personal
protection system and are intended to protect the patient, healthcare personnel,
and operating room personnel against contamination, exposure of infectious bodily
fluids, and the transfer of microorganisms and particulate material. The togas are
sterile and single-use only. | | | | |
| Device Description: | The Steri-Shield Flyte Hybrid Togas are single use, sterile, disposable devices that
comprise part of the Steri-Shield Flyte Hybrid Personal Protection System. They are
intended to be worn by healthcare personnel to protect the patient and healthcare | | | | |

5

4100 E. Milham Ave. Kalamazoo, MI 49001 t: 269 329 7000 f: 269 389 5412 www.stryker.com

Image /page/5/Picture/1 description: The image shows the word "stryker" in a bold, sans-serif font. The word is all lowercase, and there is a registered trademark symbol to the right of the "r". The word is in black and the background is white.

personnel against contamination, exposure of infectious bodily fluids and the transfer of microorganisms and particulate material. The devices are prescription use.

Device Models:

DescriptionPart Numbers
Stryker Steri-Shield Flyte Hybrid Zippered Togas,
Standard Lens0408-8X1-000 Series
Stryker Steri-Shield Flyte Hybrid Zippered Togas, Peel
Away Lens0408-8X1-100 Series
Stryker Steri-Shield Flyte Hybrid Pullover Togas0408-7X1-000 Series

Results of performance testing demonstrate that the functionality, integrity, and Performance Data (Non safety and effectiveness of the Steri-Shield Flyte Hybrid Togas are sufficient for Clinical Tests): their intended use and support a determination of substantial equivalence.

Summary of Performance Testing

Biocompatibility testing was performed on the subject device in accordance with ANSI/AAMI/ISO 10993-1:2009: Biological Evaluation of Medical Devices-Part 1: Evaluation and AAMI Standards and Recommended Practices, Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices. Results of testing validate the subject device is non-cytotoxic, non-sensitizing, and a negligible irritant.

Stryker Steri-Shield Flyte Hybrid Togas will be available only in sterile packaged form. The sterile product will be terminally sterilized using ethylene oxide (EO). The sterilization method was validated and performed in accordance with ANSI/AAMI/ISO 11135-1:2007, Sterilization of health care products - Ethylene oxide. A sterility assurance level of 10 ° has been validated for this product.

Comparison to Predicate Device:

| Description | Stryker Steri-Shield Flyte
Togas (K073017)
(Predicate) | Stryker Steri-Shield Flyte
Hybrid Togas
(Subject) | Explanation of Difference |
|---------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Classification/
Regulation | Class II | Class II | Identical |
| Regulation | 21 CFR 878.4040 Surgical
Apparel | 21 CFR 878.4040 Surgical
Apparel | Identical |
| Product Code | FYA | FYA | Identical |
| Description | Stryker Steri-Shield Flyte
Togas (K073017)
(Predicate) | Stryker Steri-Shield Flyte
Hybrid Togas
(Subject) | Explanation of Difference |
| Intended Use | The Stryker Steri-Shield Flyte
Togas are components of a
personal protection system
and are intended to protect
the patient, health care
personnel and operating
room personnel against
contamination, exposure of
infectious bodily fluids, the
transfer of microorganisms
and particulate materials. | The Stryker Steri-Shield Flyte
Hybrid Togas are components
of a personal protection
system and are intended to
protect the patient, health care
personnel and operating room
personnel against
contamination, exposure of
infectious bodily fluids, the
transfer of microorganisms and
particulate materials.
The togas are sterile and single
use only. | Identical |
| Target Population | Operating room personnel | Operating room personnel | Identical |
| Conditions for Use | Single Use/Disposable | Single Use/Disposable | Identical |
| Materials | | | |
| Hood Region | Polypropylene and polyester | Polypropylene | Steri-Shield Flyte Hybrid
products utilizes a more
breathable material in
the hood region. |
| Filter | Polypropylene and Acrylic | Polypropylene and Acrylic | Identical |
| Lens: Standard
(Non-Peelaway) | Clear Polycarbonate | Clear Polycarbonate | Identical |
| Lens: Peelaway | Clear PET Laminate | Clear PET Laminate | Identical |
| Front and Sleeves
(Barrier Material) | Polypropylene and polyester | Polypropylene and polyester | Similar. Steri-Shield Flyte
Hybrid front and sleeves
use an improved grade of
the material, which
increases manufacturing
efficiencies. |
| Back and Shoulder
Ties | polypropylene | polypropylene | Identical |
| Waist Ties | Polypropylene and polyester | Polypropylene and polyester | Identical |
| Cuffs | Polyester | Polyester | Identical |
| Zipper | Polyester, Nylon, and Vinyl | Polyester, Nylon, and Vinyl | Identical |
| Zipper Guard | polypropylene | polypropylene | Identical |
| Color | Hood region material: Blue
Front/Sleeve material: Blue | Hood region material: Light
blue
Front/Sleeve material: Blue | Similar. Steri-Shield Flyte
Hybrid hood region
material is light blue in
color instead of blue. |
| | Back material: Blue
Filter material: White | Back material: Blue
Filter material: White | |
| Physical/ Mechanical Specifications | Cuffs: White | Cuffs: White | |
| Description | Stryker Steri-Shield Flyte
Togas (K073017)
(Predicate) | Stryker Steri-Shield Flyte
Hybrid Togas
(Subject) | Explanation of Difference |
| Lint Level (ISO 9073
part 10 ) | Compliant - Pass | Compliant - Pass | Specification met. Steri-
Shield Flyte Hybrid Togas
use a different hood
region material. The filter
material was not tested
as part of the initial 510k
but was tested for the
Steri-Shield Flyte Hybrid
510k. |
| Tensile Strength (BS
EN 29073-3) | Compliant - Pass | Compliant - Pass | Specification met. Steri-
Shield Flyte Hybrid hood
region material has a
lower tensile strength,
but it still meets the
specification. The filter
material was not tested
as part of the initial 510k
but was tested for the
Steri-Shield Flyte Hybrid
510k. |
| Tear Resistance
(Flyte Hybrid: ASTM
D 5587-08; Flyte:
ASTM D 5733) | Compliant - Pass | Compliant - Pass | Specification met. ASTM
D5733 was withdrawn in
2008; therefore, a
different test standards
were followed. The filter
material was not tested
as part of the initial 510k,
but was tested for the
Steri-Shield Flyte Hybrid
510k. |
| Evaporative
resistance (ASTM F
1868 ) | Not Previously Tested | Compliant - Pass | Specifications met.
Evaporative Resistance
was not previously tested
as part of the initial Steri-
Shield Flyte 510k. |
| Bacterial Filtration
Efficiency
per ASTM F2101-07 | Compliant - Pass | Compliant - Pass | Specifications met. |
| Particulate Filtration
Efficiency
per ASTM F2299-03 | Compliant - Pass | Compliant - Pass | Specifications met. |
| | | | |
| Description | Stryker Steri-Shield Flyte
Togas (K073017)
(Predicate) | Stryker Steri-Shield Flyte
Hybrid Togas
(Subject) | Explanation of Difference |
| Viral Penetration
(per ASTM F1671)
Level 4 Critical Zone
as defined in
AAMI/ANSI PB70 | Hood region material: Pass
requirements for Level 4
Protection. | Hood region material: Material
not designed to meet Level 4
protection and was not tested
for viral penetration | Specifications met. |
| | Front/Sleeve material: Pass
requirements for Level 4
Protection. | Front/Sleeve material: Pass
requirements for Level 4
Protection. | |
| | Sleeve Seam: Pass
requirements for Level 4
Protection. | Sleeve Seam: Pass
requirements for Level 4
Protection. | |
| Water Resistance:
Impact Penetration
(per AATCC 42)
Level 1 Critical Zone | Hood region Material: Pass
requirements for Level 1
Protection. | Hood region Material: Pass
requirements for Level 1
Protection. | Specifications met. |
| as defined in
AAMI/ANSI PB70 | Back material: Pass
requirements for Level 1
Protection. | Back material: Pass
requirements for Level 1
Protection. | |
| | All other protective seams:
Pass requirements for Level 1
Protection. | All other protective seams:
Pass requirements for Level 1
Protection. | |
| General Safety and Performance | | | |
| Biocompatibility | | | |
| in vitro cytotoxicity | Under the conditions of the
study, non-cytotoxic | Under the conditions of the
study, non-cytotoxic | Identical |
| primary skin
irritation | Under the conditions of the
study, not an irritant | Under the conditions of the
study, not an irritant | Identical |
| skin sensitization | Under the conditions of the
study, not a sensitizer | Under the conditions of the
study, not a sensitizer | Identical |
| Flammability | No Flame Spread per 16 CFR
Part 1610 | No Flame Spread per 16 CFR
Part 1610 | Identical |
| Shelf Life | 3 years | 1 year | Similar – the intent is to
extend the shelf life for
the subject device upon
successful completion of
aging studies |
| Finished (Terminal)
Product Sterilization
Method | SAL 10-6
Terminally sterilized via
Ethylene Oxide in accordance
with ISO 11135-1 | SAL 10-6
Terminally sterilized via
Ethylene Oxide in accordance
with ISO 11135-1 | Identical |
| Packaging | Individually packaged in a
Poly-Tyvek pouch | Individually packaged in a Poly-Tyvek pouch | Identical |
| Description | Stryker Steri-Shield Flyte
Togas (K073017)
(Predicate) | Stryker Steri-Shield Flyte
Hybrid Togas
(Subject) | Explanation of Difference |
| Labeling | Adhesive backed label placed
on carton and pouch label
printed directly onto the
Tyvek.
Label specified part
description, quantity,
sterilization method, lot
number, expiration date, and
contact information.
No known contraindications. | Adhesive backed label placed
on carton and pouch label
printed directly onto the Tyvek.
Label specified part
description, quantity,
sterilization method, lot
number, expiration date, and
contact information.
No known contraindications. | Identical |

6

Image /page/6/Picture/1 description: The image shows the word "Stryker" in a bold, sans-serif font. The word is all in lowercase letters except for the first letter, which is capitalized. A small registered trademark symbol is located to the upper right of the letter "r" at the end of the word. The word is in black and the background is white.

7

Image /page/7/Picture/1 description: The image shows the word "stryker" in a bold, sans-serif font. The word is all lowercase except for the first letter, which is uppercase. A small registered trademark symbol is located to the upper right of the letter "r".

8

Image /page/8/Picture/1 description: The image shows the Stryker logo in black and white. The logo is a stylized wordmark with a distinctive font. The word "Stryker" is written in all lowercase letters, with the "r" having a unique curved shape. A registered trademark symbol is located to the upper right of the "r".

9

Image /page/9/Picture/1 description: The image shows the word "stryker" in a bold, sans-serif font. The letters are all connected, and the word is in black. There is a registered trademark symbol to the right of the letter "r". The logo is simple and modern.

Conclusion/ Substantial Equivalence (SE) Rationale:

The Stryker Steri-Shield Flyte Hybrid Togas are substantially equivalent in intended use, technological characteristics, safety, and effectiveness to the previously cleared Stryker Steri-Shield Flyte Togas. The products have the same fundamental scientific technology, basic design, functional characteristics and applications. The modifications introduced raise no new issues of safety and effectiveness. Therefore, the Stryker Steri-Shield Flyte Hybrid Togas are substantially equivalent to the existing predicate devices.